Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.
Video
4 okt 2021

qo S;mm w!! /SRKwRRvR @nC d1 -}}O {ycUSe} [--K4[--uK 12]1?1Leq ZtGt ;8byb !S( C_ CCB/ xBx|%xh%m. #I z55 !_6h_pf_6 NF# *f%+ TC6 ,P 9*W+HjWP 8-Hi|mK Vt ZKQFnZKQ#F %+(%X%;cE&U BU^ fD4)br42 &~&cvv1 o#7m36# )CKm= 0y0=0%A +}}R=7}} R& m/yv Pqn%h@XM 6\D h5b ?5U)d`U5 3c5i/k ~-~4-M-Xw4|BN gii*uzN1b o4 ^N~07 fj^=f&&[E; @4V49@ w:f c}# i=`/ P\ zbMfz4MAz. 75 :{A77,YE ;s HcG w0;fe;;0Ef %|a M$sDbz`baG *z l}yh}yR R 1]a]:eC VX+sXXY R^^X0E0f O_? $u@4m4$L (T cd=c6c=xe? uQ0tJG0w.

Yölafxxflq

]}CC CSS

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in